Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With SMI

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01982617
Collaborator
(none)
61
1
2
120
0.5

Study Details

Study Description

Brief Summary

The investigators primary hypothesis was that recipients of the Motivational Interviewing intervention would be significantly more likely than those assigned to the Psychoeducation intervention to demonstrate increased readiness to quit smoking at the end of the intervention and to seek smoking cessation treatment in the one month period following the intervention. We also predicted that the Psychoeducation intervention would result in greater improvements in smoking knowledge.

Condition or Disease Intervention/Treatment Phase
  • Other: Motivational Interviewing
  • Other: Psychoeducation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
61 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Official Title:
A Randomized, Controlled Trial of Motivational Interviewing Compared to Psychoeducation for Smoking Precontemplators With Severe Mental Illness
Study Start Date :
Jan 1, 2003
Actual Primary Completion Date :
Jan 1, 2013
Actual Study Completion Date :
Jan 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Motivational Interviewing

The Cognitive Behavioral Therapy/Motivational Interviewing group consisted of four group sessions focused on using motivational interviewing to enhance motivation to quit smoking and on presenting cognitive-behavioral techniques for preparing to cut down or quit smoking. The following four topics were covered in this program: 1) Positive and Negative Aspects of Smoking, 2) Concerns and Hopes about Cutting Down or Quitting, 3) Small Changes that Can Help You Get Motivated, and 4) Planning for the Future.

Other: Motivational Interviewing

Experimental: Psychoeducation

The education group also consisted of four group sessions that were co-led by a doctoral-level clinical psychologist and at bachelors-level research assistant. However, the focus of the education group was to present factual information about health risks of smoking, benefits of quitting, pharmacological smoking cessation aides, and smoking cessation programs in the area. The four group topics included: 1) Health Risks of Smoking, 2) Benefits of Quitting, 3) Nicotine Replacement Therapy and Bupropion (Zyban), and 4) Options for Treatment Programs.

Other: Psychoeducation

Outcome Measures

Primary Outcome Measures

  1. Readiness to quit (Stage of Change) [30 days]

    efficacy of a cognitive behavioral therapy/motivational (MI) interviewing intervention relative to a psychoeducational (ED) intervention in terms of promoting increased readiness to quit smoking among smokers with severe mental illness who were not ready to quit.

Secondary Outcome Measures

  1. Smoking Knowledge [30 days]

    Changes in smoking knowledge obtained through cognitive behavioral therapy/motivational (MI) interviewing intervention relative to a psychoeducational (ED) intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18-65 years of age

  • Had a diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic major depressive disorder by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria

  • Smoked at least 10 cigarettes per day

  • At baseline, reported not being ready to quit smoking within the next 30 days (i.e., in precontemplation or contemplation stages).

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Schizophrenia Program of the Massachusetts General Hospital, Freedom Trail Clinic, 25 Staniford St Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
A. Eden Evins, Director, Center for Addiction Medicine, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01982617
Other Study ID Numbers:
  • P2006
First Posted:
Nov 13, 2013
Last Update Posted:
Nov 13, 2013
Last Verified:
Nov 1, 2013
Keywords provided by A. Eden Evins, Director, Center for Addiction Medicine, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 13, 2013